title: Addition of rubidomycin to induction treatment with vincristine, prednisone, and L-asparaginase in standard-risk childhood acute lymphocytic leukemia (study ALL V): a report on behalf of the Dutch Childhood Leukemia Study Group.
authors.forename: A
authors.initials: A
authors.lastname: van der Does-van den Berg
authors.forename: E R
authors.initials: ER
authors.lastname: van Wering
authors.forename: J
authors.initials: J
authors.lastname: de Koning
authors.forename: J A
authors.initials: JA
authors.lastname: Rammeloo
authors.forename: G
authors.initials: G
authors.lastname: Solbu
authors.forename: S
authors.initials: S
authors.lastname: Suciu
authors.forename: G E
authors.initials: GE
authors.lastname: van Zanen
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001215:Asparaginase / Q000008:administration & dosage; D002648:Child; D002986:Clinical Trials as Topic; D003630:Daunorubicin / Q000008:administration & dosage; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D009426:Netherlands; D011241:Prednisone / Q000008:administration & dosage; D012074:Remission Induction; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D014750:Vincristine; D001215:Asparaginase; D011241:Prednisone; D003630:Daunorubicin